Literature DB >> 14724818

Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years.

Alex Straumann1, Hans-Peter Spichtin, Leticia Grize, Kathleen A Bucher, Christoph Beglinger, Hans-Uwe Simon.   

Abstract

BACKGROUND & AIMS: Primary eosinophilic esophagitis is a chronic, increasingly recognized, interleukin 5-driven inflammatory disorder of the esophagus. The leading symptom in adults is uniform attacks of dysphagia, and the established histologic sign is a dense eosinophilic infiltration of the esophageal epithelium. Before this study, the natural course of eosinophilic esophagitis had not been defined and information regarding potential long-term risks was lacking.
METHODS: This prospective case series included 30 adult patients with eosinophilic esophagitis (22 men and 8 women; mean age, 40.6 years) whose diagnosis had been made >1 year before study debut based on typical history, consistent endoscopic abnormalities, and infiltration of the esophageal epithelium with >24 eosinophils/high-power field. After a mean of 7.2 years, patients underwent a comprehensive follow-up examination.
RESULTS: All patients survived the study period in good health and stable nutritional state. Dysphagia persisted in 29 patients, exerting a major negative effect on socioprofessional activities on 1 patient and a minor impact on 15. Attacks of dysphagia were more frequent in patients with blood eosinophilia or pronounced endoscopic alterations. The esophageal eosinophilic infiltration persisted in all symptomatic patients, but cell numbers spontaneously decreased significantly (78.7 vs. 40.3 cells/high-power field). The inflammatory process evoked fibrosis of the esophageal lamina propria but did not spread to the stomach or duodenum. No case evolved to a hypereosinophilic syndrome.
CONCLUSIONS: Eosinophilic esophagitis, a primary and chronic disease restricted to the esophagus, leads to persistent dysphagia and structural esophageal alterations but does not impact the nutritional state. To date, no malignant potential has been associated with this disease.

Entities:  

Mesh:

Year:  2003        PMID: 14724818     DOI: 10.1053/j.gastro.2003.09.024

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  179 in total

Review 1.  Epidemiology and Natural History of Eosinophilic Esophagitis.

Authors:  Evan S Dellon; Ikuo Hirano
Journal:  Gastroenterology       Date:  2017-08-01       Impact factor: 22.682

2.  Fluticasone and food allergen elimination reverse sub-epithelial fibrosis in children with eosinophilic esophagitis.

Authors:  Samer M A Abu-Sultaneh; Paul Durst; Virginia Maynard; Yoram Elitsur
Journal:  Dig Dis Sci       Date:  2010-05-11       Impact factor: 3.199

3.  Long-term outcomes in pediatric-onset esophageal eosinophilia.

Authors:  Charles W DeBrosse; James P Franciosi; Eileen C King; Bridget K Buckmeier Butz; Allison B Greenberg; Margaret H Collins; J Pablo Abonia; Amal Assa'ad; Philip E Putnam; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2011-06-02       Impact factor: 10.793

4.  Involvement of mast cells in eosinophilic esophagitis.

Authors:  J Pablo Abonia; Carine Blanchard; Bridget Buckmeier Butz; Heather F Rainey; Margaret H Collins; Keith Stringer; Philip E Putnam; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2010-06-09       Impact factor: 10.793

5.  Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.

Authors:  Amir F Kagalwalla; Noorain Akhtar; Samantha A Woodruff; Bryan A Rea; Joanne C Masterson; Vincent Mukkada; Kalyan R Parashette; Jian Du; Sophie Fillon; Cheryl A Protheroe; James J Lee; Katie Amsden; Hector Melin-Aldana; Kelley E Capocelli; Glenn T Furuta; Steven J Ackerman
Journal:  J Allergy Clin Immunol       Date:  2012-04-01       Impact factor: 10.793

Review 6.  A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis.

Authors:  John William Jacobs; Stuart Jon Spechler
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

7.  Advances in GERD: Current Developments in the Management of Acid-Related GI Disorders.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-03

8.  Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999.

Authors:  Charles W DeBrosse; Margaret H Collins; Bridget K Buckmeier Butz; Casey L Allen; Eileen C King; Amal H Assa'ad; J Pablo Abonia; Philip E Putnam; Marc E Rothenberg; James P Franciosi
Journal:  J Allergy Clin Immunol       Date:  2010-07       Impact factor: 10.793

9.  Epidemiology of eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Gastroenterol Clin North Am       Date:  2014-03-19       Impact factor: 3.806

Review 10.  Eosinophilic gastroenteritis: a review.

Authors:  Hwa Eun Oh; Runjan Chetty
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.